#CampbellSoup $CPB: Q4 EPS of $0.63 was slightly higher than the $0.62 forecast. Revenue slightly missed, $2.3B vs. $2.32B forecast.

#Catalent Inc $CTLT: Q4 EPS outperformed expectations at $0.65 vs. $0.47 forecast. Revenue exceeded forecasts, $1.3B vs. $1.22B forecast.#Earnings

Catalent Inc (#CTLT), the actual #earnings per share (EPS) for the reported period were $0.2114, slightly below the forecasted value of $0.2154. Additionally, the revenue for the same period came in at $1.12 billion, meeting the forecasted value of $1.12 billion. #Catalent
Novartis in the lead to acquire cancer drug developer MorphoSys—Could Novo, Lilly become first trillion-dollar healthcare companies? — Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply--http://bit.ly/w28kSd #novartis #morphosys #mergersandacquisitions #novonordisk #elililly #obesity #wegovy #drugmanufacturing #catalent #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Cafepharma

Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.

Cafepharma
Bloomington’s econ development commish OKs tax abatement report, city council review next

Catalent, tax abatement, Bloomington economic development commission, Andrea “De” de la Rosa, Alex Crowley, Malcolm Webb, Eric Zorn, Vanessa McClary, Geoff McKim, Matt Flaherty, Larry Allen, Union at Crescent, Urban Station, The Foundry, Cook Pharmica d/b/a Catalent Biologics (2015), Catalent Indiana, LLC 18, Catalent Indiana, LLC 26, Catalent Indiana, LLC 26, Hoosier Energy, Woolery Mill Ventures, LLC, Southern Knoll/Milestone Ventures, Real America

The B Square

Here, in the gray-skied, limestone-quarried college town, the other critical industry is #healthcare. The city’s second largest employer is a #pharmaceutical company, #Catalent.

#Bloomington recently gave them a $43 million+ tax break. A Catalent manager assured the city that the company performs well in economic downturns.

Now, they're cutting 400 employees.

The IDS: https://www.idsnews.com/article/2022/11/pharmaceutical-company-catalent-lay-off-400-bloomington-employees

Pharmaceutical company Catalent to lay off 400 Bloomington employees

Affected employees will be notified by Dec. 2.

Indiana Daily Student
Company email: Catalent’s Bloomington operation to cut 400 jobs

Catalent, pharma, pharmaceutical, layoffs, jobs, land, expansion, tax abatement

The B Square